17 Hrs
Source:
البلاد
Lawsuits Touch Popular GLP-1 Drugs
The article discusses the controversy surrounding drugs containing GLP-1 used to treat obesity and diabetes. These drugs are facing legal claims from consumers who allege that they cause a rare loss of vision resulting from anterior ischemic optic neuropathy. The article explains that this condition is rare, often appears suddenly in the morning, and leads to a sudden loss of sight in one eye. Treating this condition is difficult, and manufacturers emphasize that current studies do not establish a direct relationship between GLP-1 medications and this condition, pointing out risk factors such as advanced age, diabetes, high blood pressure, and high cholesterol. It also notes that patients often have risk factors related to chronic illnesses, and experts stress the importance of consulting a doctor before stopping the medication, as no proven treatments currently exist to reverse optic nerve damage.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)